ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0048

Integrative Spatial Proteomics and Single-Cell RNA Sequencing Unveil Molecular Complexity in Rheumatoid Arthritis for Novel Therapeutic Targeting

Xue Wang1, Fei Wang2, Sílvia Sisó2, Archana Iyer2, Heather Knight2, Lori Duggan2, Yingli Yang2, Liang Jin2, Baoling Cui2, Yupeng He3, Jan Schejbal2, Lucy Phillips2, Bohdan Harvey4 and Yu Tian2, 1AbbVie, South San Francisco, CA, 2AbbVie, Worcester, MA, 3AbbVie, North Chicago, IL, 4AbbVie, Cambridge, MA

Meeting: ACR Convergence 2025

Keywords: Bioinformatics, proteomics, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0019–0048) Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent inflammation, fibroblast proliferation and progressive joint damage. Understanding the heterogeneity of RA and identifying therapeutic targets remain challenging using traditional bulk transcriptomics alone, as it lacks the spatial and protein-level resolution needed to fully capture disease and tissue complexities. While scRNA-seq provides a high-resolution of dynamics of gene expression at the single-cell level, it lacks the topographical or spatial context.

Methods: In this study, we applied Laser Capture Microdissection (LCM) coupled with mass spectrometry-based proteomics to analyze histopathological niches of the RA synovium, enabling the identification of protein expression profiles of the diseased synovial lining and sublining microenvironments compared to their healthy counterparts. To enhance our understanding of cellular dynamics within the dissected regions, we further integrated the proteomic dataset with single-cell RNA sequencing (scRNA-seq) and deduced cell type enrichment including T cells, fibroblasts, NK cells, myeloid cells, B cells and synovial endothelial cells.

Results: Using the in-house spatial proteomics workflow, we generated a protein expression abundance dataset containing 3,818 quantified proteins. protein expression changes were more pronounced between disease conditions than between different histopathological compartments. Key pathogenetic RA proteins like membrane proteins (TYROBP, AOC3, SLC16A3, TCIRG1 and NCEH1), and extracellular matrix (ECM) proteins (PLOD2, OGN and LUM) showed different expression patterns in diseased synovium compartments. Integration of scRNAseq and spatial proteomics provide cellular and molecular landscapes of cell type/cluster enrichments in distinct histopathological regions, highlighting fibroblasts enrichment in RA fibrous sublining regions and immune cells enrichment in RA immune sublining regions.

Conclusion: By combining high-resolution spatial proteomics and transcriptomic analyses, we provide novel insights into the molecular mechanisms driving RA and highlight potential protein targets for therapeutic intervention. This integrative approach offers a more comprehensive view of RA synovial pathology and mitigates the limitations of traditional bulk transcriptomics in target discovery.


Disclosures: X. Wang: None; F. Wang: None; S. Sisó: None; A. Iyer: AbbVie/Abbott, 3; H. Knight: AbbVie/Abbott, 3; L. Duggan: AbbVie/Abbott, 3; Y. Yang: None; L. Jin: None; B. Cui: None; Y. He: AbbVie/Abbott, 3; J. Schejbal: AbbVie/Abbott, 3; L. Phillips: AbbVie/Abbott, 3; B. Harvey: AbbVie/Abbott, 3, 11; Y. Tian: Abbvie, 3.

To cite this abstract in AMA style:

Wang X, Wang F, Sisó S, Iyer A, Knight H, Duggan L, Yang Y, Jin L, Cui B, He Y, Schejbal J, Phillips L, Harvey B, Tian Y. Integrative Spatial Proteomics and Single-Cell RNA Sequencing Unveil Molecular Complexity in Rheumatoid Arthritis for Novel Therapeutic Targeting [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/integrative-spatial-proteomics-and-single-cell-rna-sequencing-unveil-molecular-complexity-in-rheumatoid-arthritis-for-novel-therapeutic-targeting/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrative-spatial-proteomics-and-single-cell-rna-sequencing-unveil-molecular-complexity-in-rheumatoid-arthritis-for-novel-therapeutic-targeting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology